PANDA-1 A Multicenter, Double-Masked, Randomized,
Laufzeit: 01.01.2018 - 31.12.2021
imported
Kurzfassung
PANDA-1 A Multicenter, Double-Masked, Randomized,
Dose-Ranging Trial to Evaluate the Efficacy and
Safety of Conbercept Intravitreal Injection in
Subjects with Neovascular Age-related Macular
Degeneration